#CHROM	POS	REF	ALT	Gene_ID	Gene_name	HGVSc	HGVSg	Intron_number	gnomADg_AF	Effect_category	Functional_consequence	Phenotype (OMIM)	Source
4	155486360	A	G	ENSG00000171564	FGB	ENST00000302068.4:c.115-600A>G	4:g.155486360A>G	1/7	.	change_sre	pseudoexon_inclusion	Afibrinogenemia (202400)	vazDrago_2017
5	7883859	T	C	ENSG00000124275	MTRR	ENST00000264668.2:c.984+469T>C	5:g.7883859T>C	6/14	9.554099960951135e-05	change_sre	pseudoexon_inclusion	Homocystinuria, type cbIE (236270)	vazDrago_2017
11	108141209	GGTAA	G	ENSG00000149311	ATM	ENST00000278616.4:c.2839-579_2839-576del	11:g.108141212_108141215del	18/62	.	change_sre	pseudoexon_inclusion	Ataxia-telangiectasia (208900)	vazDrago_2017
11	108158168	A	G	ENSG00000149311	ATM	ENST00000278616.4:c.3994-159A>G	11:g.108158168A>G	26/62	.	change_sre	pseudoexon_inclusion	Ataxia-telangiectasia (208900)	vazDrago_2017
13	100958030	A	G	ENSG00000175198	PCCA	ENST00000376285.1:c.1285-1416A>G	13:g.100958030A>G	14/23	.	change_sre	pseudoexon_inclusion	Propionic acidemia (606054)	vazDrago_2017
X	32470726	C	G	ENSG00000198947	DMD	ENST00000357033.4:c.3603+2053G>C	X:g.32470726C>G	26/78	.	change_sre	pseudoexon_inclusion	Becker muscular dystrophy (300376)	vazDrago_2017
X	100654735	C	T	ENSG00000102393	GLA	ENST00000218516.3:c.640-801G>A	X:g.100654735C>T	4/6	4.5296001189853996e-05	change_sre	pseudoexon_inclusion	Fabry disease (301500)	vazDrago_2017
X	107813924	G	A	ENSG00000188153	COL4A5	ENST00000328300.6:c.385-719G>A	X:g.107813924G>A	6/52	.	change_sre	pseudoexon_inclusion	Alport Syndrome (301050)	vazDrago_2017
11	67816907	G	A	ENSG00000110719	TCIRG1	ENST00000265686.3:c.1887+146G>A	11:g.67816907G>A	15/19	.	change_sre	exon_extension	Autosomal recessive osteopetrosis (259700)	vazDrago_2017
12	48380015	A	C	ENSG00000139219	COL2A1	ENST00000380518.3:c.1527+104T>G	12:g.48380015A>C	23/53	.	new_splice_acceptor	exon_extension	Stickler syndrome (108300)	vazDrago_2017
3	193335986	G	A	ENSG00000198836	OPA1	ENST00000361908.3:c.557-672G>A	3:g.193335986G>A	4/29	.	new_splice_acceptor	pseudoexon_inclusion	Optic atrophy plus syndrome (125250)	vazDrago_2017
3	193335990	G	A	ENSG00000198836	OPA1	ENST00000361908.3:c.557-668G>A	3:g.193335990G>A	4/29	.	new_splice_acceptor	pseudoexon_inclusion	Optic atrophy plus syndrome (125250)	vazDrago_2017
8	30999982	A	G	ENSG00000165392	WRN	ENST00000298139.5:c.3234-160A>G	8:g.30999982A>G	26/34	.	new_splice_acceptor	pseudoexon_inclusion	Werner syndrome (277700)	vazDrago_2017
17	78090422	A	G	ENSG00000171298	GAA	ENST00000302262.3:c.2190-345A>G	17:g.78090422A>G	15/19	.	new_splice_acceptor	exon_extension	Pompe disease (232300)	vazDrago_2017
20	6074846	C	T	ENSG00000101311	FERMT1	ENST00000217289.4:c.1139+740G>A	20:g.6074846C>T	9/14	3.184899833286181e-05	new_splice_acceptor	pseudoexon_inclusion	Kindler syndrome (173650)	vazDrago_2017
X	32366860	A	C	ENSG00000198947	DMD	ENST00000357033.4:c.5326-215T>G	X:g.32366860A>C	37/78	.	new_splice_acceptor	pseudoexon_inclusion	Duchenne muscular dystrophy (310200)	vazDrago_2017
X	33032666	A	T	ENSG00000198947	DMD	ENST00000357033.4:c.93+5590T>A	X:g.33032666A>T	2/78	.	new_splice_acceptor	pseudoexon_inclusion	Becker muscular dystrophy (30376)	vazDrago_2017
X	38260946	G	A	ENSG00000036473	OTC	ENST00000039007.4:c.540+265G>A	X:g.38260946G>A	5/9	.	new_splice_acceptor	pseudoexon_inclusion	Ornithine transcarbamylase deficiency (311250)	vazDrago_2017
X	85223644	A	T	ENSG00000188419	CHM	ENST00000357749.2:c.315-4587T>A	X:g.85223644A>T	4/14	.	new_splice_acceptor	pseudoexon_inclusion	Choroideremia (303100)	vazDrago_2017
X	107852872	A	G	ENSG00000188153	COL4A5	ENST00000328300.6:c.2395+2750A>G	X:g.107852872A>G	29/52	.	new_splice_acceptor	pseudoexon_inclusion	Alport Syndrome (301050)	vazDrago_2017
X	133628822	T	A	ENSG00000165704	HPRT1	ENST00000298556.7:c.485+1202T>A	X:g.133628822T>A	6/8	.	new_splice_acceptor	pseudoexon_inclusion	Lesch–Nyhan syndrome (300322)	vazDrago_2017
9	21968346	T	C	ENSG00000147889	CDKN2A	ENST00000498124.1:c.*151-105A>G	9:g.21968346T>C	3/3	.	new_splice_donor	exon_extension	Malignant melanona (155601)	vazDrago_2017
19	54633399	C	G	ENSG00000105618	PRPF31	ENST00000321030.4:c.1374+654C>G	19:g.54633399C>G	13/13	.	new_splice_donor	exon_extension	Retinitis pigmentosa (600138)	vazDrago_2017
1	22215993	G	A	ENSG00000142798	HSPG2	ENST00000374695.3:c.574+481C>T	1:g.22215993G>A	6/96	3.186500180163421e-05	new_splice_donor	pseudoexon_inclusion	Schwartz-Jampel Syndrome (255800)	vazDrago_2017
1	94484082	T	C	ENSG00000198691	ABCA4	ENST00000370225.3:c.5196+1056A>G	1:g.94484082T>C	36/49	.	new_splice_donor	pseudoexon_inclusion	Stargardt disease (248200)	vazDrago_2017
1	98045449	G	C	ENSG00000188641	DPYD	ENST00000370192.3:c.1129-5923C>G	1:g.98045449G>C	10/22	0.01335499994456768	new_splice_donor	pseudoexon_inclusion	5-fluorouracil toxicity (274270)	vazDrago_2017
1	100672742	T	C	ENSG00000137992	DBT	ENST00000370132.4:c.1018-550A>G	1:g.100672742T>C	8/10	.	new_splice_donor	pseudoexon_inclusion	Maple syrup urine disease, type II (248600)	vazDrago_2017
1	215967783	T	C	ENSG00000042781	USH2A	ENST00000307340.3:c.9959-4159A>G	1:g.215967783T>C	50/71	.	new_splice_donor	pseudoexon_inclusion	Usher syndrome (276901)	vazDrago_2017
1	216039721	G	A	ENSG00000042781	USH2A	ENST00000307340.3:c.8845+628C>T	1:g.216039721G>A	44/71	.	new_splice_donor	pseudoexon_inclusion	Usher syndrome (276901)	vazDrago_2017
2	26500642	A	G	ENSG00000138029	HADHB	ENST00000317799.5:c.442+614A>G	2:g.26500642A>G	7/15	.	new_splice_donor	pseudoexon_inclusion	Mitochondrial trifunctional protein deficiency (609015)	vazDrago_2017
2	47635062	T	G	ENSG00000095002	MSH2	ENST00000233146.2:c.212-478T>G	2:g.47635062T>G	1/15	.	new_splice_donor	pseudoexon_inclusion	Lynch syndrome (120435)	vazDrago_2017
2	71889030	G	T	ENSG00000135636	DYSF	ENST00000410020.3:c.5003+1249G>T	2:g.71889030G>T	45/55	.	new_splice_donor	pseudoexon_inclusion	Miyoshi muscular dystrophy 1(254130)	vazDrago_2017
4	17500790	T	C	ENSG00000151552	QDPR	ENST00000281243.5:c.436+2552A>G	4:g.17500790T>C	4/6	.	new_splice_donor	pseudoexon_inclusion	Hyperphenylalaninemia, BH4-deficient, C (261630)	vazDrago_2017
4	108945190	G	T	ENSG00000138796	HADH	ENST00000603302.1:c.636+471G>T	4:g.108945190G>T	5/8	.	new_splice_donor	pseudoexon_inclusion	Hyperinsulinemic hypoglycemia (609975)	vazDrago_2017
5	42700896	A	G	ENSG00000112964	GHR	ENST00000230882.4:c.618+792A>G	5:g.42700896A>G	6/9	.	new_splice_donor	pseudoexon_inclusion	Inherited growth-hormone insensitivity (604271)	vazDrago_2017
5	112115546	G	A	ENSG00000134982	APC	ENST00000457016.1:c.532-941G>A	5:g.112115546G>A	5/15	.	new_splice_donor	pseudoexon_inclusion	Familial Adenomatous Polyposis (175100)	vazDrago_2017
5	112158419	C	T	ENSG00000134982	APC	ENST00000457016.1:c.1408+731C>T	5:g.112158419C>T	11/15	.	new_splice_donor	pseudoexon_inclusion	Familial Adenomatous Polyposis (175100)	vazDrago_2017
6	49404228	G	T	ENSG00000146085	MUT	ENST00000274813.3:c.1957-892C>A	6:g.49404228G>T	11/12	.	new_splice_donor	pseudoexon_inclusion	Methylmalonic aciduria (251000)	vazDrago_2017
6	51746236	A	G	ENSG00000170927	PKHD1	ENST00000371117.3:c.7350+1655T>C	6:g.51746236A>G	46/66	.	new_splice_donor	pseudoexon_inclusion	Polycystic kidney and hepatic disease (263200)	vazDrago_2017
6	76593963	T	G	ENSG00000196586	MYO6	ENST00000369977.3:c.2417-1758T>G	6:g.76593963T>G	23/34	.	new_splice_donor	pseudoexon_inclusion	Deafness, autosomal dominant 22 (606346)	vazDrago_2017
7	117280015	C	T	ENSG00000001626	CFTR	ENST00000003084.6:c.3718-2477C>T	7:g.117280015C>T	22/26	6.375499651767313e-05	new_splice_donor	pseudoexon_inclusion	Cystic Fibrosis (2197700)	vazDrago_2017
9	98226337	T	C	ENSG00000185920	PTCH1	ENST00000331920.6:c.2561-2057A>G	9:g.98226337T>C	15/23	.	new_splice_donor	pseudoexon_inclusion	Gorlin syndrome (109400)	vazDrago_2017
10	126100239	G	C	ENSG00000065154	OAT	ENST00000368845.5:c.199+303C>G	10:g.126100239G>C	2/9	.	new_splice_donor	pseudoexon_inclusion	Gyrate atrophy of choroid and retina (258870)	vazDrago_2017
11	5247102	A	C	ENSG00000244734	HBB	ENST00000335295.4:c.316-146T>G	11:g.5247102A>C	2/2	.	new_splice_donor	pseudoexon_inclusion	Beta-Thalassemia (613985)	vazDrago_2017
11	17465872	T	C	ENSG00000006071	ABCC8	ENST00000389817.3:c.1333-1013A>G	11:g.17465872T>C	8/38	.	new_splice_donor	pseudoexon_inclusion	Hyperinsulinemic hypoglycemia (256450)	vazDrago_2017
13	49046098	A	G	ENSG00000139687	RB1	ENST00000267163.4:c.2490-1398A>G	13:g.49046098A>G	23/26	.	new_splice_donor	pseudoexon_inclusion	Retinoblastoma (180200)	vazDrago_2017
15	48721629	T	C	ENSG00000166147	FBN1	ENST00000316623.5:c.6872-961A>G	15:g.48721629T>C	56/65	.	new_splice_donor	pseudoexon_inclusion	Marfan syndrome (154700)	vazDrago_2017
16	2107460	C	T	ENSG00000103197	TSC2	ENST00000219476.3:c.848+281C>T	16:g.2107460C>T	9/41	.	new_splice_donor	pseudoexon_inclusion	Tuberous sclerosis (613254)	vazDrago_2017
16	8926102	C	T	ENSG00000140650	PMM2	ENST00000268261.4:c.640-15479C>T	16:g.8926102C>T	7/7	.	new_splice_donor	pseudoexon_inclusion	Congenital Disorder of Glycosylation (212065)	vazDrago_2017
16	56917770	C	T	ENSG00000070915	SLC12A3	ENST00000438926.2:c.1670-191C>T	16:g.56917770C>T	13/25	3.186300091329031e-05	new_splice_donor	pseudoexon_inclusion	Gitelman’s Syndrome (263800)	vazDrago_2017
16	56927219	C	T	ENSG00000070915	SLC12A3	ENST00000438926.2:c.2548+253C>T	16:g.56927219C>T	21/25	.	new_splice_donor	pseudoexon_inclusion	Gitelman’s Syndrome (263800)	vazDrago_2017
17	29487248	C	T	ENSG00000196712	NF1	ENST00000358273.4:c.288+1137C>T	17:g.29487248C>T	3/57	.	new_splice_donor	pseudoexon_inclusion	Neurofibromatosis (162200)	vazDrago_2017
18	77470825	C	T	ENSG00000060069	CTDP1	ENST00000299543.7:c.863+389C>T	18:g.77470825C>T	6/12	.	new_splice_donor	pseudoexon_inclusion	Congenital cataracts facial dysmorphism neuropathy syndrome (604168)	vazDrago_2017
19	39074134	A	G	ENSG00000196218	RYR1	ENST00000359596.3:c.14647-1449A>G	19:g.39074134A>G	101/105	.	new_splice_donor	pseudoexon_inclusion	Central core disease (117000)	vazDrago_2017
22	50502853	A	C	ENSG00000100427	MLC1	ENST00000311597.5:c.895-226T>G	22:g.50502853A>C	10/11	.	new_splice_donor	pseudoexon_inclusion	Megalencephalic leukoencephalopathy with subcortical cysts (604004)	vazDrago_2017
X	9711844	A	C	ENSG00000101850	GPR143	ENST00000467482.1:c.659-131T>G	X:g.9711844A>C	5/8	.	new_splice_donor	pseudoexon_inclusion	Ocular albinism (300500)	vazDrago_2017
X	20191268	A	C	ENSG00000177189	RPS6KA3	ENST00000379565.3:c.1228-279T>G	X:g.20191268A>C	14/21	.	new_splice_donor	pseudoexon_inclusion	Coffin–Lowry syndrome (303600)	vazDrago_2017
X	31219364	G	A	ENSG00000198947	DMD	ENST00000357033.4:c.9807+2714C>T	X:g.31219364G>A	67/78	.	new_splice_donor	pseudoexon_inclusion	Duchenne muscular dystrophy (310200)	vazDrago_2017
X	37657051	A	G	ENSG00000165168	CYBB	ENST00000378588.4:c.675-1157A>G	X:g.37657051A>G	6/12	.	new_splice_donor	pseudoexon_inclusion	Chronic granulomatous disease (306400)	vazDrago_2017
X	66942551	A	G	ENSG00000169083	AR	ENST00000374690.3:c.2450-118A>G	X:g.66942551A>G	6/7	.	new_splice_donor	pseudoexon_inclusion	Complete androgen insensitivity syndrome (300068)	vazDrago_2017
X	135737600	A	T	ENSG00000102245	CD40LG	ENST00000370629.2:c.347-915A>T	X:g.135737600A>T	3/4	.	new_splice_donor	pseudoexon_inclusion	Hyper IgM Syndrome, type 1 (308230)	vazDrago_2017
X	154131652	G	A	ENSG00000185010	F8	ENST00000360256.4:c.5998+529C>T	X:g.154131652G>A	18/25	.	new_splice_donor	pseudoexon_inclusion	Hemophilia A (306700)	vazDrago_2017
18	21132700	C	T	ENSG00000141458	NPC1	ENST00000269228.5:c.1554-1009G>A	18:g.21132700C>T	9/24	.	new_splice_donor	pseudoexon_inclusion	Niemann-Pick disease type C (257220)	vazDrago_2017
12	108961426	G	C	ENSG00000136003	ISCU	ENST00000311893.9:c.418+382G>C	12:g.108961426G>C	4/4	.	strengthening_acceptor	pseudoexon_inclusion	Myopathy with lactic acidosis, hereditary (255125)	vazDrago_2017
15	42697047	G	C	ENSG00000092529	CAPN3	ENST00000397163.3:c.1782+1072G>C	15:g.42697047G>C	14/23	.	strengthening_acceptor	pseudoexon_inclusion	Limb-girdle muscular dystrophy type 2A (253600)	vazDrago_2017
X	154131240	C	T	ENSG00000185010	F8	ENST00000360256.4:c.5999-798G>A	X:g.154131240C>T	18/25	.	strengthening_acceptor	pseudoexon_inclusion	Hemophilia A (306700)	vazDrago_2017
X	77269725	A	G	ENSG00000165240	ATP7A	ENST00000341514.6:c.2407-434A>G	X:g.77269725A>G	10/22	.	strengthening_donor	exon_extension	Menkes disease (309400)	vazDrago_2017
X	153641699	G	A	ENSG00000102125	TAZ	ENST00000299328.5:c.284+110G>A	X:g.153641699G>A	3/10	.	strengthening_donor	exon_extension	Barth syndrome (302060)	vazDrago_2017
1	216247476	T	C	ENSG00000042781	USH2A	ENST00000307340.3:c.5573-834A>G	1:g.216247476T>C	27/71	3.183900116709992e-05	strengthening_donor	pseudoexon_inclusion	Usher syndrome (276901)	vazDrago_2017
4	155530122	T	A	ENSG00000171557	FGG	ENST00000336098.3:c.667-320A>T	4:g.155530122T>A	6/8	.	strengthening_donor	pseudoexon_inclusion	Afibrinogenemia (202400)	vazDrago_2017
21	33039383	C	G	ENSG00000142168	SOD1	ENST00000270142.6:c.240-188C>G	21:g.33039383C>G	3/4	.	strengthening_donor	pseudoexon_inclusion	Amyotrophic lateral sclerosis 1 (105400)	vazDrago_2017
22	30070689	T	A	ENSG00000186575	NF2	ENST00000338641.4:c.1341-136T>A	22:g.30070689T>A	12/15	.	strengthening_donor	pseudoexon_inclusion	Neurofibromatosis (101000)	vazDrago_2017
X	148568762	T	C	ENSG00000010404	IDS	ENST00000340855.6:c.1007-133A>G	X:g.148568762T>C	7/8	.	strengthening_donor	pseudoexon_inclusion	Mucopolysaccharidosis (309900)	vazDrago_2017
3	136003251	A	G	ENSG00000114054	PCCB	ENST00000469217.1:c.714+462A>G	3:g.136003251A>G	7/15	.	strengthening_donor	pseudoexon_inclusion	Propionic acidemia (606054)	vazDrago_2017
5	112158423	A	T	ENSG00000134982	APC	ENST00000457016.1:c.1408+735A>T	5:g.112158423A>T	11/15	.	strengthening_donor	pseudoexon_inclusion	Familial Adenomatous Polyposis (175100)	vazDrago_2017
12	88494960	T	C	ENSG00000198707	CEP290	ENST00000552810.1:c.2991+1655A>G	12:g.88494960T>C	26/53	0.0001277599949389696	strengthening_donor	pseudoexon_inclusion	Leber congenital amaurosis (611755)	vazDrago_2017
13	32919384	T	G	ENSG00000139618	BRCA2	ENST00000544455.1:c.6937+594T>G	13:g.32919384T>G	12/27	0.00031875999411568046	strengthening_donor	pseudoexon_inclusion	Breast cancer (114480)	vazDrago_2017
19	1386643	C	G	ENSG00000115286	NDUFS7	ENST00000233627.9:c.17-1167C>G	19:g.1386643C>G	1/7	.	strengthening_donor	pseudoexon_inclusion	Leigh syndrome (256000)	vazDrago_2017
X	13768358	A	G	ENSG00000046651	OFD1	ENST00000340096.6:c.935+706A>G	X:g.13768358A>G	9/22	.	strengthening_donor	pseudoexon_inclusion	Retinitis pigmentosa (300424)	vazDrago_2017
X	31279418	T	C	ENSG00000198947	DMD	ENST00000357033.4:c.9225-285A>G	X:g.31279418T>C	62/78	.	strengthening_donor	pseudoexon_inclusion	Becker muscular dystrophy (30376)	vazDrago_2017
X	32460274	G	T	ENSG00000198947	DMD	ENST00000357033.4:c.3787-843C>A	X:g.32460274G>T	27/78	.	strengthening_donor	pseudoexon_inclusion	Duchenne muscular dystrophy (310200)	vazDrago_2017
